1. Beautiful faces have variable reward value: fMRI and behavioral evidence;Aharon;Neuron,2001
2. Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers;Andreotti;J. Clin. Endocrinol. Metab.,1995
3. Catecholamine modulation of prefrontal cortical cognitive function;Arnsten;Trends Cogn. Sci.,1998
4. The debate over dopamine's role in reward: the case for incentive salience;Berridge;Psychopharmacology (Berl.),2007
5. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline;Biller;J. Clin. Endocrinol. Metab.,1996